109194 ⎘
Structure or type of the nucleic acid; Chemical structure; Nature of the modification; Conjugate intercalating or cleaving agent
EXTRACELLULAR VESICLE COMPRISING A BIOLOGICALLY ACTIVE MOLECULE AND A DUAL CLEAVABLE LINKER
#2COMPOSITIONS AND METHODS FOR MODULATING APOLIPOPROTEIN C-III EXPRESSION
#3CONJUGATED ANTISENSE COMPOUNDS AND THEIR USE
#4MULTIVALENT CARGO-CARRYING COMPLEXES AND USES THEREOF
#5TARGETING LIGAND AND USE THEREOF
#6COMPOSITIONS AND METHODS FOR MODULATING APOLIPOPROTEIN C-III EXPRESSION
#7Compositions and methods for modulating apolipoprotein (a) expression
#8COVALENT APTAMERS
#9EXTRACELLULAR VESICLE-ASO CONSTRUCTS TARGETING STAT6
#10CONJUGATED ANTISENSE COMPOUNDS AND THEIR USE
#11COMPOSITIONS AND METHODS FOR MODULATING TTR EXPRESSION
#12PEPTIDE NUCLEIC ACID CONJUGATES
#13LIGHT-INDUCIBLE CRISPR/CAS9 SYSTEM FOR GENOME EDITING
#14COMPOSITIONS AND METHODS FOR MODULATING TTR EXPRESSION
#15COMPOSITIONS AND METHODS FOR MODULATING APOLIPOPROTEIN C-III EXPRESSION
#16iRNA AGENTS WITH BIOCLEAVABLE TETHERS
#17COMPOSITIONS AND METHODS
#18Compositions and methods for modulating apolipoprotein (a) expression
#19COMPOSITIONS AND METHODS FOR MODULATING TTR EXPRESSION
#20COMPOSITIONS AND METHODS FOR MODULATING HBV EXPRESSION
#21Peptide nucleic acid conjugates
#22Conjugated antisense compounds and their use
#23COMPOSITIONS AND METHODS FOR MODULATING HBV EXPRESSION
#24iRNA agents with biocleavable tethers
#25Compositions and methods for modulating apolipoprotein (a) expression
#26Compositions and methods for modulating apolipoprotein C-III expression
#27Composition
#28CD38 ligand-drug conjugates for targeted cancer therapy
#29Particle-nucleic acid conjugates and therapeutic uses related thereto
#30Compositions and methods for modulating TTR expression
#31COMPOSITIONS AND METHODS
#32iRNA agents with biocleavable tethers
#33Aptamer construct
#34Compositions and methods for modulating apolipoprotein (a) expression
#35Compositions and methods for modulating apolipoprotein C-III expression
#36Compositions and methods
#37Compositions and methods for modulating HBV expression
#38Particle-nucleic acid conjugates and therapeutic uses related thereto
#39Compositions and methods for modulating apolipoprotein (a) expression
#40Compositions and methods for modulating apolipoprotein C-III expression
#41Conjugated antisense compounds and their use
#42Compositions and methods for gene silencing
#43Conjugated antisense compounds and their use
#44STRONGLY BOUND BASE-MODIFIED OLIGONUCLEOTIDES
#45Use of Oligonucleotides with Modified Bases as Antiviral Agents
#46INTERCALATING TRIPLEXES AND DUPLEXES USING ARYL NAPHTHOIMIDAZOL AND PROCESS FOR THE PREPARATION THEREOF
#47Compositions and methods for inhibiting expression of anti-apoptotic genes
#48Cleavage kit, and gene therapy by using the same and nucleic acid cleavage detection apparatus
#49iRNA agents with biocleavable tethers
#50Oligoribonucleotides and uses thereof
#51Compounds for Hydrolyzing Ribonucleic Acids (RNA's)
#52Stable and selective formation of hoogsteen-type triplexes and duplexes using twisted intercalating nucleic acids (TINA) and process for the preparation of TINA
#53HUMAN RIBOSOMAL DNA (rDNA) AND RIBOSOMAL RNA (rRNA) NUCLEIC ACIDS AND USES THEREOF
#54Compositions and methods for inhibiting expression of anti-apoptotic genes
#55Crosslinking agent, crosslinking method, method of controlling gene expression, and method of examining gene function
#56Method of Making an Artificial Nuclease for Anti-viral, Anti-bacterial Applications
#57Compounds and Their Use for Specific and Simultaneous Inhibition of Genes Involved In Diseases and Related Drugs
#58Antisense agents combining strongly bound base-modified oligonucleotide and artificial nuclease
#59Human ribosomal DNA (rDNA) and ribosomal RNA (rRNA) nucleic acids and uses thereof
#60Macrocyclic chelators for gene-silencing or gene disruption
#61Compositions and methods for inhibiting expression of anti-apoptotic genes
#62Antisense and antigene therapeutics with improved binding properties and methods for their use
#63IRNA agents with biocleavable tethers
#64Compositions and methods for inhibiting expression of anti-apoptotic genes
#65Nucleic acid carrier compositions and methods for their synthesis
#66Modulation of gene expression using DNA-DNA hybrids
#67Oligonucleotide complexes for use as anti-viral therapeutics
#68Conjugated antisense compounds and their use